Register Interest for the TRP Target Selection & Drug Design Summit

Thank you to our speakers, sponsors and delegates for joining us at the 2nd TRP Target Selection & Drug Design Summit.

Register your interest to be the first to hear updates about the 2027 meeting.

Explore the 2026 Event Guide

  • 70+ attendees from world-leading RLT companies
  • 20+ expert speakers including Novartis, Bayer, AstraZeneca & Convergent Therapeutics
  • 12+ C-Suite speakers with direct influence on their companies' pipelines
  • 6+ novel targets explored, including PD-L1, DLL3, B7-H3, CEACAM5, KLK3 and COF-01
  • 6+ Hours of Built-In Networking alongside pioneers in the RLT industry
  • 3 Big Pharma Companies Presenting on the advancements in their RLT pipeline
2nd TRP Target Selection & Drug Design Summit 2026 brochure image